A Study in People With Abnormal Fat Levels in the Blood

Completed · Phase 2 · Has a placebo group

Conditions studied: Dyslipidemia

In brief

The purposes of this study are to determine: * The safety of the study medication and any side effects that might be associated with it; * Whether the study medication can help patients with low levels of 'good' cholesterol (HDL-C) and high blood fats or triglycerides (TG); * How much of the study medication should be given to patients; * How the study medication compares to fenofibrate (Lofibra), a drug used for people with low levels of HDL-C and high levels of TG.

Key facts

Study ID
NCT00116519
Run by
Eli Lilly and Company
People needed
300
Starts
2005-07-01
Expected to finish
2006-10-01
Last updated by the study team
2007-01-26

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.